Südharz Klinikum

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle et al. · Journal of Cancer Research and Clinical Oncology · 2006 · 190 citations · Full text

Hematological Malignancy, Medicine, Metronomic Therapy +10

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study

Jens Buentzel, Oliver Micke, Irenäus A. Adamietz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 146 citations

Oncology, Intravenous Amifostine, Radiation Therapy +8

Potential MRI Interpretation Model: Differentiation of Benign from Malignant Breast Masses

Ansgar Malich, Dorothee Fischer, Susanne Wurdinger et al. · American Journal of Roentgenology · 2005 · 119 citations

Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology

Oliver Micke, Frank Bruns, Michael Glatzel et al. · European Journal of Integrative Medicine · 2009 · 113 citations

Radiation Medicine, Oncology, Radiation Therapy +9

Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology

Ralph Muecke, Lutz Schomburg, Michael Glatzel et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 113 citations

Radiation Medicine, Radiation Therapy, Gynecologic Radiation Oncology +9